跳至主要内容
临床试验/NCT07166666
NCT07166666尚未招募不适用

Study Comparing Atomizerd Midazolam & Fentanyl and Dexmedomidine for Procedural Sedation in Adult and Pediatric Patient (2 to 60 Years Old)

Oman Medical Speciality Board1 个研究点 分布在 1 个国家目标入组 128 人开始时间: 2025年9月1日最近更新:
干预措施
相关药物

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
128
试验地点
1
主要终点
depth of sedtion

研究概览

简要总结

To evaluate the depth of sedation, as well as onset, and recovery times, satisfaction of sedation , adverse events associated with Atomized Midazolam & Fentanyl and Dexmedetomidine during procedural sedation in a diverse population spanning from 2 to 60 years old at these three prominent Omani healthcare facilities.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
2 Years 至 60 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • inclusion criteria:
  • Patients aged 2 to 60 years.
  • Patients undergoing EM procedures requiring sedation.
  • Exclusion criteria:
  • Patients with contraindications to any of the sedation agents being studied.
  • Patients with a history of adverse reactions or allergies to the study medications.
  • Drug interactions: Patients taking certain medications that may interact adversely with the study medications.
  • Drug Abuser
  • Pregnancy and breastfeeding
  • Patients with significant cardiovascular or respiratory compromise.
  • Patients with nasal disorder (nasal trauma, epistaxis)
  • Patients unable to provide informed consent or those with cognitive impairment.
  • Patients who are < 2 year of age or > 60 year of age.
  • Patient underwent procedure sedation for imaging

排除标准

  • 未提供

研究组 & 干预措施

midazolame $ fentanyl

Other

use as compare between two group

干预措施: atomizer (Device)

midazolame $ fentanyl

Other

use as compare between two group

干预措施: rescue medication (Drug)

midazolame $ fentanyl

Other

use as compare between two group

干预措施: Midazolam (Drug)

midazolame $ fentanyl

Other

use as compare between two group

干预措施: fentanyl (Drug)

dexetomidate

Other

use as compare to other group

干预措施: atomizer (Device)

dexetomidate

Other

use as compare to other group

干预措施: rescue medication (Drug)

dexetomidate

Other

use as compare to other group

干预措施: Dexmedetomidine (Drug)

dexetomidate

Other

use as compare to other group

干预措施: Placabo (Drug)

结局指标

主要结局

depth of sedtion

时间窗: 1 year

using MOAA/S score, Modified Observer's Assessment of Alertness/Sedation Scale , as 0 high score for deep sedation, 5 not in deep sedation

次要结局

未报告次要终点

研究者

发起方
Oman Medical Speciality Board
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Ghaliya Al Noofli

Principal Investigator

Oman Medical Speciality Board

研究点 (1)

Loading locations...

相似试验